Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Daclizumab in multiple sclerosis: a high-yield extension study.
Use of rituximab in multiple sclerosis: current progress and future perspectives.
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
The cell biology of CNS myelination.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
How integrated are neurology and palliative care services? Results of a multicentre mapping exercise.
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Will the real multiple sclerosis please stand up?
Neurological involvement in Primary Sjögren Syndrome.
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Enhancement of Chemotactic Cell Aggregation by Haptotactic Cell-To-Cell Interaction.
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.
Clinical proteomics of enervated neurons.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice.
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
…
next ›
last »